Total Payments
$4,910
2024 Payments
$140.65
Companies
28
Transactions
105
Medicare Patients
5,255
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$2,809 (57.2%)
Consulting$1,988 (40.5%)
Education$113.88 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,809 | 99 | 57.2% |
| Consulting Fee | $1,988 | 4 | 40.5% |
| Education | $113.88 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| InfoBionic, Inc | $1,988 | 4 | $0 (2023) |
| Abbott Laboratories | $1,012 | 15 | $0 (2023) |
| Edwards Lifesciences Corporation | $280.61 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $190.71 | 12 | $0 (2023) |
| Medtronic Vascular, Inc. | $136.77 | 2 | $0 (2019) |
| Amgen Inc. | $134.62 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $133.30 | 10 | $0 (2019) |
| Boston Scientific Corporation | $122.71 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $113.65 | 2 | $0 (2020) |
| PFIZER INC. | $93.64 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140.65 | 8 | Baxter Healthcare ($24.71) |
| 2023 | $2,326 | 22 | InfoBionic, Inc ($1,988) |
| 2022 | $278.76 | 16 | E.R. Squibb & Sons, L.L.C. ($83.61) |
| 2021 | $406.66 | 4 | Abbott Laboratories ($276.23) |
| 2020 | $381.36 | 9 | Abbott Laboratories ($325.03) |
| 2019 | $1,116 | 43 | Abbott Laboratories ($186.46) |
| 2018 | $108.37 | 1 | Boston Scientific Corporation ($108.37) |
| 2017 | $152.45 | 2 | Abbott Laboratories ($152.45) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardio-renal | ||||||
| 09/09/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Not Applicable | ||||||
| 08/01/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Bone Health | ||||||
| 06/27/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| Category: Sleep Apnea testing | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 02/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: DIABETES | ||||||
| 12/12/2023 | InfoBionic, Inc | — | Consulting Fee | Cash or cash equivalent | $325.00 | General |
| 11/28/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2023 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/11/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2023 | InfoBionic, Inc | — | Consulting Fee | Cash or cash equivalent | $325.00 | General |
| 08/08/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Cardiology | ||||||
| 07/25/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/20/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: EndoVenous Therapies | ||||||
| 07/18/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| Category: Cardiovascular | ||||||
| 06/21/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2023 | Medtronic, Inc. | HARMONY (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Heart Valves | ||||||
| 05/14/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Heart Failure | ||||||
| 05/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: DIABETES | ||||||
| 03/21/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/14/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $25.58 | General |
| Category: Not Applicable | ||||||
| 03/03/2023 | InfoBionic, Inc | — | Consulting Fee | Cash or cash equivalent | $487.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,336 | 2,940 | $951,982 | $238,144 |
| 2022 | 22 | 1,488 | 2,844 | $1.2M | $299,511 |
| 2021 | 21 | 1,301 | 1,954 | $1.0M | $276,114 |
| 2020 | 22 | 1,130 | 1,656 | $1.0M | $259,796 |
Total Patients
5,255
Total Services
9,394
Medicare Billing
$1.1M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 313 | 547 | $169,191 | $48,766 | 28.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 36 | 41 | $140,400 | $35,826 | 25.5% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 27 | 27 | $106,427 | $27,113 | 25.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 154 | 163 | $104,646 | $22,349 | 21.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 65 | 474 | $69,806 | $17,077 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 89 | 131 | $54,365 | $15,511 | 28.5% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 23 | 23 | $46,712 | $14,542 | 31.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 59 | 395 | $71,325 | $13,919 | 19.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 61 | 435 | $51,887 | $12,726 | 24.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 39 | 156 | $36,006 | $6,993 | 19.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $23,850 | $5,264 | 22.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 36 | $10,944 | $3,280 | 30.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $13,639 | $2,987 | 21.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 53 | 57 | $12,312 | $2,930 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $8,925 | $2,223 | 24.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 189 | 206 | $9,888 | $2,035 | 20.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 16 | 23 | $3,864 | $1,280 | 33.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 17 | 46 | $3,283 | $1,203 | 36.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 14 | 15 | $9,630 | $727.89 | 7.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 16 | 25 | $2,475 | $547.20 | 22.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 24 | 24 | $1,899 | $445.28 | 23.5% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 28 | 28 | $509.60 | $399.56 | 78.4% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 50 | 50 | $197,087 | $50,935 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 292 | 575 | $177,675 | $49,379 | 27.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2022 | 50 | 50 | $195,000 | $49,293 | 25.3% |
About Dr. Evan May, M.D
Dr. Evan May, M.D is a Cardiovascular Disease healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295939486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evan May, M.D has received a total of $4,910 in payments from pharmaceutical and medical device companies, with $140.65 received in 2024. These payments were reported across 105 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,809).
As a Medicare-enrolled provider, May has provided services to 5,255 Medicare beneficiaries, totaling 9,394 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location El Paso, TX
- Active Since 06/12/2007
- Last Updated 08/02/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295939486
Products in Payments
- CardioMEMS HF System (Device) $229.73
- ELIQUIS (Drug) $159.04
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $150.18
- Reveal LINQ (Device) $136.77
- ENTRESTO (Drug) $133.30
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $130.43
- Mitra Clip system (Device) $128.41
- Durata Defibrillation ICD Lead (Device) $127.61
- Allure Quadra RF CRT Pacemaker (Device) $125.30
- Unify Assura CRT Defibrillator (Device) $119.62
- WATCHMAN (Device) $108.37
- Assurity Pacemaker (Device) $107.71
- Confirm Rx (Device) $101.79
- LifeVest (Device) $87.74
- VERQUVO (Drug) $86.55
- CAMZYOS (Drug) $76.98
- XARELTO (Drug) $76.03
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $71.45
- JARDIANCE (Drug) $65.74
- Corlanor (Drug) $65.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in El Paso
Dr. Mohammad Raja, Md, MD
Cardiovascular Disease — Payments: $419,675
Cardiovascular Disease $419,675
Tu Cao, Do, DO
Cardiovascular Disease — Payments: $103,141
Cardiovascular Disease $103,141
Mr. Edward Assi, D.o, D.O
Cardiovascular Disease — Payments: $100,993
Cardiovascular Disease $100,993
Oscar Munoz, Md, MD
Cardiovascular Disease — Payments: $64,052
Cardiovascular Disease $64,052
Ediberto Soto-Cora, M.d, M.D
Cardiovascular Disease — Payments: $47,917
Cardiovascular Disease $47,917
Dr. Arshad Ali, Md, MD
Cardiovascular Disease — Payments: $26,863
Cardiovascular Disease $26,863